You have no items in your shopping cart.
Search results for: 'active'
> 95% as analyzed by SDS-PAGE and HPLC.
7.8 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg- RecombinantMCP-1/CCL2,Rat [orb1494632]
> 98% as analyzed by SDS-PAGE.
10~15 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg > 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg, 1 mg> 98% as analyzed by SDS-PAGE.
8.3 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg> 98% as analyzed by SDS-PAGE.
8.7 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg, 1 mg> 95% as analyzed by SDS-PAGE and HPLC.
42 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg> 98% as analyzed by SDS-PAGE.
70-90 kDa, observed by reducing SDS-PAGE.
HEK 293
1 mg, 10 μg, 50 μg- RecombinantFasR,Human [orb1494650]
> 95% as analyzed by SDS-PAGE.
17~29 kDa, observed by reducing SDS-PAGE.
HEK 293
1 mg, 10 μg, 50 μg - RecombinantCT‑1,Mouse [orb1494652]
> 95% as analyzed by SDS-PAGE.
22~27 kDa, observed by reducing SDS-PAGE.
HEK 293
1 mg, 10 μg, 50 μg - RecombinantVEGF-D,Human [orb1494659]
> 95% as analyzed by SDS-PAGE and HPLC.
18-19 kDa, observed by reducing SDS-PAGE.
CHO
1 mg, 10 μg, 50 μg
